Andrew Davidoff
Overview
Explore the profile of Andrew Davidoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
1289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Castellino S, Muir A, Shah A, Shope S, McMullen K, Ruble K, et al.
Pediatr Blood Cancer
. 2009 Nov;
54(5):663-9.
PMID: 19890896
Curative therapy for childhood and adolescent cancer translates to 1 in 640 young adults being a survivor of cancer. Although acute hepato-biliary toxicity occurs commonly during pediatric cancer therapy, the...
12.
Karplus G, McCarville M, Smeltzer M, Spyridis G, Rao B, Davidoff A, et al.
J Pediatr Surg
. 2009 Apr;
44(4):665-71.
PMID: 19361624
Purpose: Children presenting with osteosarcoma and pulmonary metastases have poor survival rates. The standard approach to treating unilateral metastases is ipsilateral thoracotomy with complete resection of the metastases whenever possible....
13.
Calabrese C, Poppleton H, Kocak M, Hogg T, Fuller C, Hamner B, et al.
Cancer Cell
. 2007 Jan;
11(1):69-82.
PMID: 17222791
Cancers are believed to arise from cancer stem cells (CSCs), but it is not known if these cells remain dependent upon the niche microenvironments that regulate normal stem cells. We...
14.
Nathan P, Ness K, Greenberg M, Hudson M, Wolden S, Davidoff A, et al.
Pediatr Blood Cancer
. 2006 Jul;
49(5):704-15.
PMID: 16830322
Background: Long-term survivors of Wilms tumor and neuroblastoma may experience significant late adverse effects from their disease and its therapy. Little is known, however, about the health-related quality of life...
15.
Bocci G, Man S, Green S, Francia G, Ebos J, du Manoir J, et al.
Cancer Res
. 2004 Sep;
64(18):6616-25.
PMID: 15374976
A major obstacle compromising the successful application of many of the new targeted anticancer drugs, including angiogenesis inhibitors, is the empiricism associated with determining an effective biological/therapeutic dose because many...
16.
Streck C, Zhang Y, Zhou J, Ng C, Davidoff A
J Pediatr Surg
. 2004 Mar;
39(3):405-11.
PMID: 15017561
Purpose: Concomitant resistance, the phenomenon whereby a primary malignancy inhibits the growth of metastatic lesions, is likely caused by the production of endogenous anti-angiogenic factors. The purpose of this study...
17.
Corey B, Yang C, Wilimas J, Davidoff A, Dome J
Pediatr Blood Cancer
. 2004 Jan;
42(2):145-8.
PMID: 14752878
Background: Pleural effusion is uncommon at diagnosis of Wilms tumor. Because the clinical significance of this finding has not been reported, a retrospective review of this entity was conducted. Procedure:...
18.
Rousseau R, Haight A, Hirschmann-Jax C, Yvon E, Rill D, Mei Z, et al.
Blood
. 2002 Oct;
101(5):1718-26.
PMID: 12406881
In murine models, transgenic chemokine-cytokine tumor vaccines overcome many of the limitations of single-agent immunotherapy by producing the sequence of T-cell attraction followed by proliferation. The safety and immunologic effects...